Gliadel

Carmustine A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)

[1. An antineoplastic agent.

Molecular Formula: C₅H₉Cl₂N₃O₂

InChI: InChI=1/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)/f/h8H

InChIKey: InChIKey=DLGOEMSEDOSKAD-FZOZFQFYCY
SMILES: ClCCNC(=O)N(CCCl)N=O

CAS number 154-93-8

Names:
    Bicnu (TN)
    carmustine
    Carmustine (USAN)
    Carmustine
    carmustine
    Gliadel
    N,N'-Bis(2-chloroethyl)-N-nitrosourea
    Prestwick_997
    1,3-bis(2-chloroethyl)-1-nitroso-urea
    154-93-8

Registries:
    PubChem CID 2578
    CAS 154-93-8 (from NIST)
    ChEBI 3423
    Kegg D00254
    PubChem ID 10321906
    PubChem ID 7847320